Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Duchenne muscular dystrophy quantification: a multivariate analysis of surface EMG.

Literature DB >> 1453800

Duchenne muscular dystrophy quantification: a multivariate analysis of surface EMG.

Abstract

The paper describes a method of quantifying Duchenne muscular dystrophy which is examiner independent and uses surface electromyographic signals (EMG). A standardised protocol is proposed. Spectral parameters are first computed from digitised EMG, then a polynomial model is deduced from the evolution of each parameter. A discriminant analysis between healthy and DMD subjects leads to the determination of a discriminant plane and a level of sickness index.

Entities: Disease

Mesh：

Year: 1992 PMID： 1453800 DOI： 10.1007/bf02446966

Source DB: PubMed Journal: Med Biol Eng Comput ISSN： 0140-0118 Impact factor: 2.602

19 in total

1. A study of the reproducibility of muscle testing and certain other aspects of muscle scoring.

Authors: A M LILIENFELD; M JACOBS; M WILLIS
Journal: Phys Ther Rev Date: 1954-06

2. Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls.

Authors: J R Mendell; M A Province; R T Moxley; R C Griggs; M H Brooke; G M Fenichel; J P Miller; K K Kaiser; W King; J Robison
Journal: Arch Neurol Date: 1987-08

3. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy.

Authors: C Webster; L Silberstein; A P Hays; H M Blau
Journal: Cell Date: 1988-02-26 Impact factor: 41.582

4. Clinical trial in Duchenne dystrophy. I. The design of the protocol.

Authors: M H Brooke; R C Griggs; J R Mendell; G M Fenichel; J B Shumate; R J Pellegrino
Journal: Muscle Nerve Date: 1981 May-Jun Impact factor: 3.217

5. Myoelectric power spectrum dependence on muscular contraction level of elbow flexors.

Authors: M Hagberg; B E Ericson
Journal: Eur J Appl Physiol Occup Physiol Date: 1982

6. Quantifying human muscle strength, endurance and fatigue.

Authors: H S Milner-Brown; M Mellenthin; R G Miller
Journal: Arch Phys Med Rehabil Date: 1986-08 Impact factor: 3.966

7. Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels.

Authors: J T den Dunnen; E Bakker; E G Breteler; P L Pearson; G J van Ommen
Journal: Nature Date: 1987 Oct 15-21 Impact factor: 49.962

8. The progression of Duchenne muscular dystrophy: clinical trial of allopurinol therapy.

Authors: L M Stern; J D Fewings; A H Bretag; F J Ballard; F M Tomas; D M Cooper; E Goldblatt
Journal: Neurology Date: 1981-04 Impact factor: 9.910

9. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.

Authors: M H Brooke; G M Fenichel; R C Griggs; J R Mendell; R Moxley; J P Miller; M A Province
Journal: Muscle Nerve Date: 1983-02 Impact factor: 3.217

Duchenne muscular dystrophy quantification: a multivariate analysis of surface EMG.

1. A study of the reproducibility of muscle testing and certain other aspects of muscle scoring.

2. Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls.

3. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy.

4. Clinical trial in Duchenne dystrophy. I. The design of the protocol.

5. Myoelectric power spectrum dependence on muscular contraction level of elbow flexors.

6. Quantifying human muscle strength, endurance and fatigue.

7. Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels.

8. The progression of Duchenne muscular dystrophy: clinical trial of allopurinol therapy.

9. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.

Review 10. Myoelectrical manifestations of localized muscular fatigue in humans.

1. Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles.

Review 2. Alterations of neuromuscular junctions in Duchenne muscular dystrophy.

Review 3. Neuromuscular Development and Disease: Learning From in vitro and in vivo Models.

4. Surface EMG signals in very late-stage of Duchenne muscular dystrophy: a case study.

Review 5. The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease.